Acadia Healthcare Company, Inc.
NASDAQ:ACHC
42.02 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,928.738 | 2,610.399 | 2,314.394 | 2,089.929 | 3,107.462 | 3,012.442 | 2,836.316 | 2,810.914 | 1,794.492 | 1,004.601 | 713.408 | 407.461 | 221.373 | 62.103 |
| Cost of Revenue
| 2,246.129 | 1,493.634 | 1,334.506 | 1,241.763 | 1,840.241 | 1,778.662 | 1,650.599 | 1,659.279 | 1,054.395 | 623.834 | 445.531 | 259.135 | 167.938 | 42.36 |
| Gross Profit
| 682.609 | 1,116.765 | 979.888 | 848.166 | 1,267.221 | 1,233.78 | 1,185.717 | 1,151.635 | 740.097 | 380.767 | 267.877 | 148.326 | 53.435 | 19.743 |
| Gross Profit Ratio
| 0.233 | 0.428 | 0.423 | 0.406 | 0.408 | 0.41 | 0.418 | 0.41 | 0.412 | 0.379 | 0.375 | 0.364 | 0.241 | 0.318 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,794.895 | 203.475 | 175.258 | 157.851 | 323.212 | 307.707 | 272.998 | 258.834 | 148.991 | 64.683 | 47.22 | 26.857 | 57.74 | 3.083 |
| Selling & Marketing Expenses
| -1,618.882 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 176.013 | 203.475 | 175.258 | 157.851 | 323.212 | 307.707 | 272.998 | 258.834 | 148.991 | 64.683 | 47.22 | 26.857 | 57.74 | 3.083 |
| Other Expenses
| 514.836 | 445.595 | 390.156 | 357.528 | 539.477 | -34.507 | -24.267 | -48.323 | -36.571 | -13.65 | -7.15 | -8.112 | 24.76 | -0.918 |
| Operating Expenses
| 176.013 | 649.07 | 565.414 | 515.379 | 862.689 | 821.037 | 747.835 | 706.493 | 419.287 | 208.004 | 144.882 | 77.616 | 82.5 | 10.929 |
| Operating Income
| 506.596 | 443.903 | 414.474 | 365.606 | 404.532 | 412.743 | 437.882 | 445.142 | 320.81 | 172.763 | 122.995 | 70.71 | -29.065 | 8.814 |
| Operating Income Ratio
| 0.173 | 0.17 | 0.179 | 0.175 | 0.13 | 0.137 | 0.154 | 0.158 | 0.179 | 0.172 | 0.172 | 0.174 | -0.131 | 0.142 |
| Total Other Income Expenses Net
| -531.956 | -69.76 | -138.714 | -181.809 | -268.544 | -396.287 | -25.077 | -230.862 | -49.315 | 1.612 | -16.5 | -8.112 | -9.191 | -0.918 |
| Income Before Tax
| -25.36 | 374.143 | 275.76 | 183.797 | 135.988 | -168.954 | 236.798 | 32.955 | 164.753 | 126.154 | 69.245 | 32.829 | -38.256 | 7.158 |
| Income Before Tax Ratio
| -0.009 | 0.143 | 0.119 | 0.088 | 0.044 | -0.056 | 0.083 | 0.012 | 0.092 | 0.126 | 0.097 | 0.081 | -0.173 | 0.115 |
| Income Tax Expense
| -9.699 | 94.11 | 67.557 | 40.606 | 25.866 | 6.532 | 37.209 | 28.779 | 46.397 | 42.922 | 25.975 | 12.325 | -5.383 | 0.477 |
| Net Income
| -21.667 | 273.139 | 190.635 | 143.191 | 108.923 | -175.75 | 199.835 | 6.143 | 119.545 | 83.04 | 42.579 | 20.403 | -34.892 | 6.21 |
| Net Income Ratio
| -0.007 | 0.105 | 0.082 | 0.069 | 0.035 | -0.058 | 0.07 | 0.002 | 0.067 | 0.083 | 0.06 | 0.05 | -0.158 | 0.1 |
| EPS
| -0.24 | 3.05 | 2.3 | 1.63 | 1.24 | -2.01 | 2.3 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
| EPS Diluted
| -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.3 | 0.07 | 1.75 | 1.5 | 0.85 | 0.53 | -1.86 | 0.35 |
| EBITDA
| 638.945 | 561.672 | 521.191 | 460.862 | 568.576 | 571.575 | 580.892 | 580.245 | 384.36 | 205.43 | 140.085 | 78.692 | -24.777 | 8.872 |
| EBITDA Ratio
| 0.218 | 0.215 | 0.225 | 0.221 | 0.183 | 0.19 | 0.205 | 0.206 | 0.214 | 0.204 | 0.196 | 0.193 | -0.112 | 0.143 |